https://www.selleckchem.com/pr....oducts/way-309236-a.
© 2020 The Authors. American Journal of Medical Genetics Part B Neuropsychiatric Genetics published by Wiley Periodicals, Inc.BACKGROUND Immunosuppressed (IS) patients with Merkel cell carcinoma (MCC) have worse outcomes compared to immunocompetent (IC) patients, and it is unclear if adjuvant radiotherapy (RT) is beneficial for these patients. We sought to determine the effect of immune status on adjuvant RT efficacy regarding overall survival (OS) for patients with localized MCC. METHODS This was an observational study of National
Like
Comment
Share
